1.
Paul D, Grewal G, Jain K, Pathak S, Chhabra A, Singh J, et al. Pharmacogenomic Profiling of DPYD Mutations and Genotype‑guided Dose Adjustment to Prevent Fluoropyrimidine Toxicity in Gastrointestinal Cancer Patients: A Real‑world Study from North India. Asian Pac J Cancer Care [Internet]. 2025 Dec. 15 [cited 2026 May 29];10(4):1093-100. Available from: http://www.waocp.com/journal/index.php/apjcc/article/view/1869